{"title":"Controlling Covid-19 Needs More Than Just A Vaccine; It Requires An Integrated Control Strategy","authors":"E. Abdallah","doi":"10.38125/oajbs.000365","DOIUrl":null,"url":null,"abstract":"The ongoing worldwide pandemic of Coronavirus Disease 2019 (COVID-19), which outbroke in December 2019 in China (Wuhan) and quickly spread around the world, is the most widespread and devastating infection in the present time [1]. This virus produces a severe lower respiratory tract infection, with viral pneumonia occurring in roughly 75% of COVID-19 hospitalized patients. Despite the fact that the mortality rate associated with COVID-19 is only 2%, much less than the earlier zoonotic coronavirus epidemics such as 10 % for Severe acute respiratory syndrome (SARS) and 30% for Middle East Respiratory Syndrome (MERS) [2], and. 50% for Ebola. Accordingly, COVID-19 is not the deadliest viral disease. However, COVID-19 is more contagious than SARS and MERS and its high spread rate is fraught with hazards, requiring stringent policies and plans [3]. Interestingly, the wide range of animal species vulnerable to COVID-19 clearly implies that these viruses have the potential to overcome the species barriers, especially given the frequent interactions between predators and other small mammals that might aid interspecies transmission [4]. The scientific community has put forth a lot of efforts to combat this pandemic, and as a result, a range of vaccines have been developed. COVID-19 variants are constantly emerging, which is unfortunate. Without intervention, vaccination against COVID-19 alone could lead to continued dissemination and the generation of new variants [5], necessitating the continuous use of booster doses. In addition to continuing to develop more effective vaccinations, new integrated strategies must be established. Accordingly, the suggested integrative strategy should include:","PeriodicalId":207626,"journal":{"name":"Open Access Journal of Biomedical Science","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Access Journal of Biomedical Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.38125/oajbs.000365","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
The ongoing worldwide pandemic of Coronavirus Disease 2019 (COVID-19), which outbroke in December 2019 in China (Wuhan) and quickly spread around the world, is the most widespread and devastating infection in the present time [1]. This virus produces a severe lower respiratory tract infection, with viral pneumonia occurring in roughly 75% of COVID-19 hospitalized patients. Despite the fact that the mortality rate associated with COVID-19 is only 2%, much less than the earlier zoonotic coronavirus epidemics such as 10 % for Severe acute respiratory syndrome (SARS) and 30% for Middle East Respiratory Syndrome (MERS) [2], and. 50% for Ebola. Accordingly, COVID-19 is not the deadliest viral disease. However, COVID-19 is more contagious than SARS and MERS and its high spread rate is fraught with hazards, requiring stringent policies and plans [3]. Interestingly, the wide range of animal species vulnerable to COVID-19 clearly implies that these viruses have the potential to overcome the species barriers, especially given the frequent interactions between predators and other small mammals that might aid interspecies transmission [4]. The scientific community has put forth a lot of efforts to combat this pandemic, and as a result, a range of vaccines have been developed. COVID-19 variants are constantly emerging, which is unfortunate. Without intervention, vaccination against COVID-19 alone could lead to continued dissemination and the generation of new variants [5], necessitating the continuous use of booster doses. In addition to continuing to develop more effective vaccinations, new integrated strategies must be established. Accordingly, the suggested integrative strategy should include: